Ignite Creation Date:
2025-12-24 @ 1:33 PM
Ignite Modification Date:
2025-12-24 @ 1:33 PM
Study NCT ID:
NCT06253195
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-06-05
First Post:
2024-02-02
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
BGB-43395 Alone or as Part of Combination Therapies in Chinese Participants With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
Sponsor:
BeiGene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-01
Start Date Type:
ACTUAL
Primary Completion Date:
2026-02-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-10-26
Completion Date Type:
ESTIMATED
First Submit Date:
2024-02-02
First Submit QC Date:
None
Study First Post Date:
2024-02-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-04
Last Update Post Date:
2025-06-05
Last Update Post Date Type:
ACTUAL